SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-17-007803
Filing Date
2017-02-09
Accepted
2017-02-09 16:02:38
Documents
3

Document Format Files

Seq Description Document Type Size
1 S-3/A a17-3162_1s3a.htm S-3/A 356125
2 EX-23.1 a17-3162_1ex23d1.htm EX-23.1 2484
3 EX-23.2 a17-3162_1ex23d2.htm EX-23.2 2051
  Complete submission text file 0001104659-17-007803.txt   361853
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-215747 | Film No.: 17587528
SIC: 2835 In Vitro & In Vivo Diagnostic Substances